Abstract
Pidotimod is a synthetic dipeptide with biological and immunological activity in innate immune responses. It has been reported that pidotimod could promote functional maturation of dendritic cells, but little is known about the regulation of macrophages. Recent studies have demonstrated that M1 or M2 polarized macrophages are of great importance for responses to microorganism infection or host mediators. The aim of this study was to determine the effectiveness of pidotimod on mouse bone marrow-derived macrophage polarization and its function. The results showed that pidotimod had no influence on M1-polarized macrophage. While interestingly, a significant increase of M2 marker gene expression (Arg1, Fizz1, Ym1, MR) was observed (p < 0.01) in IL-4-induced M2 macrophage treated with pidotimod. In addition, cell surface expression of mannose receptor was dramatically enhanced using fluorescence activated cell sorter (FACS) analysis. Furthermore, the function of M2 macrophage was also determinated. The results showed that the supernatant of pidotimod-treated M2 macrophage could increase the migration (p < 0.05) and enhance the wound closure rate (p < 0.05) of MLE-12 cells. Collectively, it could be concluded that pidotimod significantly facilitated IL-4-induced M2 macrophage polarization and improves its function.
Similar content being viewed by others
References
Auteri A, Pasqui AL, Bruni F et al (1992) Effect of pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study. Pharmacol Res 26(Suppl 2):196–197
Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181:3733–3739
Bronte V, Zanovello P (2005) Regulation of immune responses by l-arginine metabolism. Nat Rev Immunol 5:641–654
Careddu P, Mei V, Venturoli V, Corsini A (1994) Pidotimod in the treatment of recurrent respiratory infections in paediatric patients. Arzneimittelforschung 44:1485–1489
Coppi G, Barchielli M (1991) Simple high-performance liquid chromatographic method for the determination of PGT/1A, a new immunostimulating drug, in biological fluids. J Chromatogr 563:385–391
Coppi G, Manzardo S (1994) Experimental immunological screening tests on pidotimod. Arzneimittelforschung 44:1411–1416
di Marco R, Condorelli F, Girardello R et al (1992) Increased rate of survival in Streptococcus pneumoniae-infected rats treated with the new immunomodulator pidotimod. Scand J Infect Dis 24:821–823
Edwards JP, Zhang X, Frauwirth KA et al (2006) Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 80:1298–1307
Giagulli C, Noerder M, Avolio M et al (2009) Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level. Int Immunopharmacol 9:1366–1373
Goerdt S, Orfanos CE (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10:137–142
Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35
Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593–604
Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964
Heilbronn LK, Campbell LV (2008) Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 14:1225–1230
Hesse M, Modolell M, La Flamme AC et al (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of l-arginine metabolism. J Immunol 167:6533–6544
Hu X, Zhang W, Wang L et al (2012) The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: pidotimod (PTD). Hum Vaccin Immunother 8:1250–1258
Ji J, Hu SL, Cui ZW et al (2013) Probiotic Bacillus amyloliquefaciens mediate M1 macrophage polarization in mouse bone marrow-derived macrophages. Arch Microbiol 195:349–356
Jiang J, Grieb B, Thyagarajan A et al (2008) Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med 21:577–584
Kang K, Reilly SM, Karabacak V et al (2008) Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab 7:485–495
Kreider T, Anthony RM, Urban JJ et al (2007) Alternatively activated macrophages in helminth infections. Curr Opin Immunol 19:448–453
Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329–333
Mantovani A, Sozzani S, Locati M et al (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555
Mantovani A, Sica A, Sozzani S et al (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677–686
Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23:344–346
Manzardo S, Falcone A, Pinzetta A et al (1994) General pharmacology of pidotimod and testing for drug interactions. Arzneimittelforschung 44:1441–1447
Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451–483
Mege JL, Mehraj V, Capo C (2011) Macrophage polarization and bacterial infections. Curr Opin Infect Dis 24:230–234
Migliorati G, D’Adamio L, Coppi G et al (1992) Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death. Immunopharmacol Immunotoxicol 14:737–748
Migliorati G, Nicoletti I, Riccardi C (1994) Immunomodulating activity of pidotimod. Arzneimittelforschung 44:1421–1424
Mikita T, Campbell D, Wu P et al (1996) Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol Cell Biol 16:5811–5820
Mookherjee N, Brown KL, Bowdish DM et al (2006) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176:2455–2464
Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73:209–212
Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958–969
Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723–737
Nair MG, Gallagher IJ, Taylor MD et al (2005) Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 73:385–394
Pollard JW (2009) Trophic macrophages in development and disease. Nat Rev Immunol 9:259–270
Raes G, De Baetselier P, Noel W et al (2002) Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol 71:597–602
Riboldi P, Gerosa M, Meroni PL (2009) Pidotimod: a reappraisal. Int J Immunopathol Pharmacol 22:255–262
Rolls A, Shechter R, London A et al (2008) Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med 5:e171
Saccani A, Schioppa T, Porta C et al (2006) p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 66:11432–11440
Satoh T, Takeuchi O, Vandenbon A et al (2010) The Jmjd3–Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11:936–944
Soehnlein O, Lindbom L (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10:427–439
Stein M, Keshav S, Harris N et al (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176:287–292
Acknowledgments
This work was supported by the grants from the planning subject of ‘the twelfth five-year-plan’ in national science and technology for the rural development in China (No.2013BAD10B03).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
S. Hu and X. Fu have contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Hu, S., Fu, X., Fu, A. et al. The regulatory peptide pidotimod facilitates M2 macrophage polarization and its function. Amino Acids 46, 1177–1185 (2014). https://doi.org/10.1007/s00726-014-1676-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-014-1676-4